login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ADMA BIOLOGICS INC (ADMA) Stock News
USA
- NASDAQ:ADMA -
US0008991046
-
Common Stock
15.69
USD
+0.27 (+1.75%)
Last: 11/18/2025, 8:00:00 PM
15.75
USD
+0.06 (+0.38%)
After Hours:
11/18/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ADMA Latest News, Press Relases and Analysis
All
Press Releases
14 hours ago - By: Zacks Investment Research
- Mentions:
NVO
ARQT
VTYX
VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know
15 hours ago - By: Zacks Investment Research
- Mentions:
GSK
ALEC
ARQT
Alector Stock Plummets 63% in a Month: Here's What You Need to Know
5 days ago - By: Zacks Investment Research
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
5 days ago - By: Zacks Investment Research
- Mentions:
ANIP
KOD
ARQT
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
6 days ago - By: Zacks Investment Research
- Mentions:
NVS
ANIP
ARQT
Novartis' Phase III Malaria Study Meets Key Non-Inferiority Endpoint
7 days ago - By: Zacks Investment Research
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?
14 days ago - By: Benzinga
- Mentions:
TECH
INSE
GEF
SKYT
...
Earnings Scheduled For November 5, 2025
a month ago - By: Zacks Investment Research
Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know
7 days ago - By: Zacks Investment Research
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors
8 days ago - By: Zacks Investment Research
- Mentions:
ANIP
EDIT
ARQT
Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y
8 days ago - By: Zacks Investment Research
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade
13 days ago - By: Zacks Investment Research
- Mentions:
ATRA
Adma Biologics (ADMA) Q3 Earnings Match Estimates
13 days ago - By: ADMA Biologics, Inc.
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
13 days ago - By: ADMA Biologics, Inc.
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Zacks Investment Research
Why Adma Biologics (ADMA) Outpaced the Stock Market Today
18 days ago - By: The Motley Fool
- Mentions:
STRL
SPXC
MMYT
ITRI
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
21 days ago - By: Zacks Investment Research
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
21 days ago - By: ADMA Biologics, Inc.
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
a month ago - By: Zacks Investment Research
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
3 months ago - By: Benzinga
- Mentions:
OEC
VTLE
DIN
INSE
...
Earnings Scheduled For August 6, 2025
2 months ago - By: Zacks Investment Research
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
2 months ago - By: Zacks Investment Research
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
3 months ago - By: Yahoo Finance
- Mentions:
VZ
ADMA Biologics, Inc. (ADMA): A Bull Case Theory
3 months ago - By: Zacks Investment Research
- Mentions:
CRMD
IMCR
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum
3 months ago - By: The Motley Fool
Adma Biologics (ADMA) Q2 Revenue Up 14%
3 months ago - By: Zacks Investment Research
- Mentions:
PBYI
Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates
3 months ago - By: ADMA Biologics, Inc.
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: ADMA Biologics, Inc.
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: ADMA Biologics, Inc.
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
4 months ago - By: ADMA Biologics, Inc.
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
4 months ago - By: Yahoo Finance
Heavy Insider Selling at ADMA Biologics Despite Earnings Strength
Please enable JavaScript to continue using this application.